The contracting authority, Leiden University Medical Centre (LUMC) has the intention to acquire a Tissector Tabletop on behalf of the department Pathology. LUMC has the intention to award the contract to Xyall B.V. ESP 405 eindhoven Netherlands. LUMC will apply the negotiation procedure without publication of a contract notice. LUMC has established that no other competitors than Xyall are, momentarily, able to meet some of the essential technical demands with respect to proven technology. The contracting authority may apply the negotiated procedure without prior notice because there is no competition for the following technical reasons and the relevant supply and service can only be provided by this specific supplier: 1. The Xyall Tissector is the sole solution that automates precise tissue dissection guided by whole-slide images – no competing system offer this level of integration or automation. Enables reproducible macrodisscection of tissue with submillimeter accuracy directly The contracting authority, Leiden University Medical Centre (LUMC) has the intention to acquire a Tissector Tabletop on behalf of the department Pathology. LUMC has the intention to award the contract to Xyall B.V. ESP 405 eindhoven Netherlands. LUMC will apply the negotiation procedure without publication of a contract notice. LUMC has established that no other competitors than Xyall are, momentarily, able to meet some of the essential technical demands with respect to proven technology. The contracting authority may apply the negotiated procedure without prior notice because there is no competition for the following technical reasons and the relevant supply and service can only be provided by this specific supplier: 1. The Xyall Tissector is the sole solution that automates precise tissue dissection guided by whole-slide images – no competing system offer this level of integration or automation. Enables reproducible macrodisscection of tissue with submillimeter accuracy directly guided from digital pathology scans. Demonstrated efficacy across peer-reviewed studies in improving nucleic acid yield and tumor purity compared to manual scraping or scalpel methods. 2. Standard practice lacks automation and is labor-intensive, inconsistent and operator-dependent. The Xyall Tissector automates a traditionally manual and time-consuming step, freeing staff for other testing. Consistent tissue enrichment reduces repeat assays and lowers wasted reagents. Compared to LCM instruments and consumables, the Xyall’s tabletop footprint and consumables offer a significant cost of advantage. Uses validated standard workflows with software assisted complete documentation of tissue selection and processing- critical for CLIA/CAP audits. Suggested delivery 1 Tissector Table top and 3 to 9 years of maintenance Conclusion By means of this call for voluntary ex ante transparency, LUMC informs parties of its intention and provides the opportunity to submit a reasoned objection against this intention. If parties have objections against the intended purchase from Xyall B.V., please inform LUMC on the last appearance of 09-03-2026 before 17:00 h. by sending an email directed at: [email protected] with reference to Jimmy Been, Procurement. When during this term no objections have been raised, LUMC is free to acquire it’s desired Tissector Table top from Xyall B.V.